Quick Read The S&P 500 has stretched 10-15% above its key moving averages, with the Nasdaq-100 surging 17.35% in one month ...

Eli Lilly (LLY) concluded the recent trading session at $903.02, signifying a -1.83% move from its prior day's close.

Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Eli Lilly (NYSE: LLY) has become the leader in a market marching toward the $100 billion mark. I'm talking about the ...

The S&P 500 has experienced a challenging two-week period marked by escalating geopolitical tensions, sector rotation into defensives, and technical deterioration. In light of this, below is a list of ...

While Eli Lilly has slightly lagged behind the SPX over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

Eli Lilly (LLY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of ...

Stocks were hovering near their session lows in afternoon trading on Tuesday as the selloff in healthcare stocks intensified, though all three major indexes were still clinging to modest gains for the ...

On May 4, 2026, Wolfe Research said the FDA received a report on April 30 through its Adverse Event Reporting System ...

Stocks were boosted in May by easing trade tensions, solid corporate earnings and signs the U.S. economy remains resilient ...